These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31288974)

  • 61. Investigational drugs for treating agitation in persons with dementia.
    Garay RP; Citrome L; Grossberg GT; Cavero I; Llorca PM
    Expert Opin Investig Drugs; 2016 Aug; 25(8):973-83. PubMed ID: 27232589
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
    Fox C; Crugel M; Maidment I; Auestad BH; Coulton S; Treloar A; Ballard C; Boustani M; Katona C; Livingston G
    PLoS One; 2012; 7(5):e35185. PubMed ID: 22567095
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.
    Bartels C; Wagner M; Wolfsgruber S; Ehrenreich H; Schneider A;
    Am J Psychiatry; 2018 Mar; 175(3):232-241. PubMed ID: 29179578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spotlight on the pharmacoeconomics of escitalopram in depression.
    Croom KF; Plosker GL
    CNS Drugs; 2004; 18(7):469-73. PubMed ID: 15139801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
    Leonpacher AK; Peters ME; Drye LT; Makino KM; Newell JA; Devanand DP; Frangakis C; Munro CA; Mintzer JE; Pollock BG; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG; Porsteinsson AP;
    Am J Psychiatry; 2016 May; 173(5):473-80. PubMed ID: 27032628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
    Leonard B; Taylor D
    J Psychopharmacol; 2010 Aug; 24(8):1143-52. PubMed ID: 20147575
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia.
    Gottfries CG; Nyth AL
    Ann N Y Acad Sci; 1991; 640():276-9. PubMed ID: 1776751
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [New formulations of olanzapine in the treatment of acute agitation].
    Bartkó G
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Escitalopram versus other antidepressive agents for depression.
    Cipriani A; Santilli C; Furukawa TA; Signoretti A; Nakagawa A; McGuire H; Churchill R; Barbui C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006532. PubMed ID: 19370639
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
    Liu CS; Chau SA; Ruthirakuhan M; Lanctôt KL; Herrmann N
    CNS Drugs; 2015 Aug; 29(8):615-23. PubMed ID: 26271310
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
    Kasper S; Sacher J; Klein N; Mossaheb N; Attarbaschi-Steiner T; Lanzenberger R; Spindelegger C; Asenbaum S; Holik A; Dudczak R
    Int Clin Psychopharmacol; 2009 May; 24(3):119-25. PubMed ID: 19367152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
    Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
    Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
    Lin YT; Hwang TJ; Shan JC; Chiang HL; Sheu YH; Hwu HG
    J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.